Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

v3.22.2
Note 8 - Accrued Liabilities
6 Months Ended
Jun. 30, 2022
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

June 30, 2022

   

December 31, 2021

 

Accrued clinical trial costs

  $ 529     $ 284  

Accrued compensation

    207       484  

Accrued research and other professional fees

    151       191  

Other liabilities

    7       7  

Total accrued liabilities

  $ 894     $ 966